Groundbreaking new medications designed to slow the development of Alzheimer's have recently been approved for private use in the UK. This treatment is now open to all eligible patients of Dr. Moghul. Please get in touch if interested, or read more below.
01
Leqembi™ and Kisunla™ are administered as an IV infusion fortnightly or monthly. They aim to clear amyloid plaques, which build up in the brain and can contribute to Alzheimer's. Through the treatment process, you will be closely monitored by the doctors and nurses at the clinic.
02
Each infusion takes around 30 minutes, administered fortnightly or monthly for up to 18 months. Typically, amyloid plaques are cleared from the brain after 12 to 18 months of treatment. A PET scan towards the end of treatment will confirm this.
03
If you have fading memory, then you could be eligible for the new treatments. After your initial consultation with Dr. Moghul, you will need a dementia clinic assessment, which includes a cognitive assessment and an MRI scan. This is to see if you have mild cognitive impairment (MCI), or mild Alzheimer's disease. The treatments are not suitable for other conditions.
04
Dr. Moghul has teamed up with Re:Cognition Health to provide his patients with the new treatments. Re:Cognition Health are the most experienced provider in the field, and were the first in Europe to use the new treatments. Dr. Moghul will be administering the treatments himself at the Winchester clinic, and the supporting team of doctors and nurses are very experienced.
05
The new treatments aren't available on the NHS and patients worldwide have already started travelling to the UK to receive this treatment. Re:Cognition Health is one of the most experienced centres, having administered over 10,000 infusions since first being involved in the clinical trials. The Winchester clinic will be convenient for patients in Hampshire, Dorset, Surrey and surrounding areas in the South of England.
Contact us today to schedule a consultation and start your journey towards better mental health.